• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Accuracy of the "Surprise Question" in predicting 90-day mortality among hospitalized patients with decompensated cirrhosis.

作者信息

Selesky Margaret, Li Lucinda, Zeng Chengbo, Yun Justin S, Bizup Grace, Indriolo Teresa, Kaplan Alyson, Liu Annie, Kavalieratos Dio, El-Jawahri Areej, Hutchinson Rebecca N, Ouchi Kei, Ufere Nneka N

机构信息

Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.

出版信息

Hepatol Commun. 2025 Jul 14;9(8). doi: 10.1097/HC9.0000000000000773. eCollection 2025 Aug 1.

DOI:10.1097/HC9.0000000000000773
PMID:40658791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12262957/
Abstract
摘要

相似文献

1
Accuracy of the "Surprise Question" in predicting 90-day mortality among hospitalized patients with decompensated cirrhosis.“意外问题”在预测失代偿期肝硬化住院患者90天死亡率中的准确性。
Hepatol Commun. 2025 Jul 14;9(8). doi: 10.1097/HC9.0000000000000773. eCollection 2025 Aug 1.
2
Symptom burden in end-stage liver disease: a prospective cohort study of the symptoms experienced by patients and the role of palliative care.终末期肝病的症状负担：一项关于患者所经历症状及姑息治疗作用的前瞻性队列研究
Therap Adv Gastroenterol. 2025 Jul 13;18:17562848251353624. doi: 10.1177/17562848251353624. eCollection 2025.
3
An educational video increases disease-related knowledge in hospitalized patients with decompensated cirrhosis.一部教育视频增加了失代偿期肝硬化住院患者的疾病相关知识。
Can Liver J. 2024 Dec 19;7(4):458-469. doi: 10.3138/canlivj-2024-0037. eCollection 2024 Dec.
4
Improving palliative and supportive care in advanced cirrhosis: the HepatoCare model of integrated collaborative care.改善晚期肝硬化的姑息治疗和支持性护理：综合协作护理的肝脏关怀模式
Intern Med J. 2023 Nov;53(11):1963-1971. doi: 10.1111/imj.16248. Epub 2023 Oct 9.
5
Statin Therapy is Associated With Lower Risk of Mortality Among Liver Transplant Candidates With Metabolic Dysfunction-associated Steatohepatitis.他汀类药物治疗与代谢功能障碍相关脂肪性肝炎的肝移植受者死亡率降低相关。
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102427. doi: 10.1016/j.jceh.2024.102427. Epub 2024 Oct 16.
6
Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.粒细胞集落刺激因子联合或不联合干细胞或祖细胞或生长因子输注治疗代偿期或失代偿期晚期慢性肝病患者。
Cochrane Database Syst Rev. 2023 Jun 6;6(6):CD013532. doi: 10.1002/14651858.CD013532.pub2.
7
A novel risk-predicted nomogram for acute kidney injury progression in decompensated cirrhosis: a double-center study in Vietnam.失代偿期肝硬化急性肾损伤进展的新型风险预测列线图：越南的一项双中心研究
Int Urol Nephrol. 2025 Feb 15. doi: 10.1007/s11255-025-04398-1.
8
Differences in the incidence of cirrhosis-associated complications between MASLD, MetALD and ALD among patients with decompensated liver cirrhosis.失代偿期肝硬化患者中，非酒精性脂肪性肝病相关肝硬化（MASLD）、代谢相关脂肪性肝病（MetALD）和酒精性肝病（ALD）之间肝硬化相关并发症发生率的差异。
PLoS One. 2025 Jun 26;20(6):e0325673. doi: 10.1371/journal.pone.0325673. eCollection 2025.
9
Prognostic communication, psychological distress, and caregiving burden among caregivers of patients with decompensated cirrhosis.失代偿期肝硬化患者照顾者的预后沟通、心理困扰及照顾负担
Liver Transpl. 2025 Jul 11. doi: 10.1097/LVT.0000000000000683.
10
AI-Cirrhosis-ECG (ACE) score for predicting decompensation and liver outcomes.用于预测失代偿和肝脏预后的人工智能-肝硬化-心电图（ACE）评分
JHEP Rep. 2025 Feb 19;7(5):101356. doi: 10.1016/j.jhepr.2025.101356. eCollection 2025 May.

本文引用的文献

1
The Surprise Question and clinician-predicted prognosis: systematic review and meta-analysis.意外问题与临床医生预测的预后：系统评价与荟萃分析
BMJ Support Palliat Care. 2024 Dec 25;15(1):12-35. doi: 10.1136/spcare-2024-004879.
2
The utility of the surprise question: A useful tool for identifying patients nearing the last phase of life? A systematic review and meta-analysis.“惊讶问题”的实用性：识别生命末期患者的有用工具？系统评价和荟萃分析。
Palliat Med. 2022 Jul;36(7):1023-1046. doi: 10.1177/02692163221099116.
3
AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis.
美国肝病研究学会实践指南：失代偿期肝硬化的姑息治疗与基于症状的管理
Hepatology. 2022 Sep;76(3):819-853. doi: 10.1002/hep.32378. Epub 2022 Apr 22.
4
How Well Does the Surprise Question Predict 1-year Mortality for Patients Admitted with COPD?“惊讶问题”预测 COPD 患者 1 年死亡率的效果如何？
J Gen Intern Med. 2021 Sep;36(9):2656-2662. doi: 10.1007/s11606-020-06512-8. Epub 2021 Jan 6.
5
Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.机器学习对肝硬化再入院和死亡的预测能力较低。
Am J Gastroenterol. 2021 Feb 1;116(2):336-346. doi: 10.14309/ajg.0000000000000971.
6
Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.终末期肝病模型-钠低估了慢加急性肝衰竭患者 90 天的死亡率风险。
J Hepatol. 2020 Dec;73(6):1425-1433. doi: 10.1016/j.jhep.2020.06.005. Epub 2020 Jun 10.
7
Increasing Health Care Burden of Chronic Liver Disease Compared With Other Chronic Diseases, 2004-2013.2004-2013 年慢性肝脏疾病导致的医疗保健负担日益加重，甚于其他慢性疾病。
Gastroenterology. 2018 Sep;155(3):719-729.e4. doi: 10.1053/j.gastro.2018.05.032. Epub 2018 May 23.
8
The "surprise question" for predicting death in seriously ill patients: a systematic review and meta-analysis.预测重症患者死亡的“意外问题”：系统评价与荟萃分析
CMAJ. 2017 Apr 3;189(13):E484-E493. doi: 10.1503/cmaj.160775.
9
Hyponatremia and mortality among patients on the liver-transplant waiting list.肝移植等待名单上患者的低钠血症与死亡率
N Engl J Med. 2008 Sep 4;359(10):1018-26. doi: 10.1056/NEJMoa0801209.
10
The National Death Index.国家死亡索引
Am J Public Health. 1983 Nov;73(11):1247-8. doi: 10.2105/ajph.73.11.1247.